Entero Healthcare Solutions Ltd (ENTERO) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Entero Healthcare Solutions achieved significant milestones in FY25, exceeding Rs. 5,000 crores in revenue, surpassing a 100,000 customer base (pharmacies and hospitals), and achieving over Rs. 100 crores in profit after tax.
- The company turned operating cash flow positive in the second half of the year.
- Entero's strategic focus remains on organic expansion in underserved markets, enhancing customer buying experience through technology, and strategic acquisitions.
- The company's presence now covers 500 districts across 20 states, serving over 95,300 retail pharmacies and 3,600 hospitals.
- Entero successfully integrated 10 acquisitions during the year, contributing Rs. 792 crores in annualized revenue.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.